Peregrine Capital Management LLC Cuts Stake in Cabot Corporation $CBT

Peregrine Capital Management LLC reduced its position in Cabot Corporation (NYSE:CBT) by 8.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,219 shares of the specialty chemicals company’s stock after selling 6,929 shares during the quarter. Peregrine Capital Management LLC’s holdings in Cabot were worth $5,439,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Public Employees Retirement System of Ohio increased its position in Cabot by 15.4% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,202 shares of the specialty chemicals company’s stock valued at $80,000 after purchasing an additional 160 shares during the period. Janney Montgomery Scott LLC raised its holdings in shares of Cabot by 2.6% in the 4th quarter. Janney Montgomery Scott LLC now owns 6,298 shares of the specialty chemicals company’s stock valued at $417,000 after purchasing an additional 161 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in shares of Cabot by 9.6% during the fourth quarter. Farther Finance Advisors LLC now owns 1,873 shares of the specialty chemicals company’s stock valued at $124,000 after purchasing an additional 164 shares in the last quarter. Gabelli Funds LLC boosted its stake in shares of Cabot by 1.3% during the third quarter. Gabelli Funds LLC now owns 13,570 shares of the specialty chemicals company’s stock valued at $1,032,000 after purchasing an additional 180 shares in the last quarter. Finally, Rothschild Investment LLC increased its holdings in Cabot by 170.4% during the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock valued at $27,000 after buying an additional 259 shares during the period. 93.18% of the stock is owned by hedge funds and other institutional investors.

Cabot Trading Down 4.5%

NYSE:CBT opened at $86.69 on Thursday. The stock has a market capitalization of $4.47 billion, a price-to-earnings ratio of 16.39, a PEG ratio of 11.94 and a beta of 0.83. Cabot Corporation has a 52 week low of $58.33 and a 52 week high of $94.53. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51. The firm has a 50 day moving average of $84.09 and a 200 day moving average of $76.27.

Cabot (NYSE:CBT) last released its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.47 by $0.14. The business had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.30 million. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The business’s revenue for the quarter was down 3.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, sell-side analysts anticipate that Cabot Corporation will post 6.34 earnings per share for the current fiscal year.

Cabot Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 29th were paid a dividend of $0.4725 per share. This is a positive change from Cabot’s previous quarterly dividend of $0.45. The ex-dividend date was Friday, May 29th. This represents a $1.89 annualized dividend and a yield of 2.2%. Cabot’s dividend payout ratio (DPR) is presently 35.73%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on CBT shares. Truist Financial initiated coverage on shares of Cabot in a research note on Monday, June 8th. They issued a “buy” rating and a $98.00 price objective for the company. UBS Group lifted their price target on Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a report on Friday, May 8th. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, June 14th. Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Finally, Mizuho lifted their target price on Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Thursday, June 25th. Two research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Cabot presently has a consensus rating of “Hold” and a consensus target price of $85.80.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.